Next-Generation Immune-Oncology Drugs Show Early Promise
March 30, 2023
Phipps, Matt
Rising Interest Rates Pose Headwind for Biotechs Needing Cash
March 18, 2022
Phipps, Matt
Broad Pullback in Biotech Provides Buying Opportunity for Specific Names
September 30, 2021
Phipps, Matt